Rend Al-Mondhiry
Rend Al-Mondhiry advises the dietary supplement, food, cosmetic, and over-the-counter medicine industries on a broad range of regulatory and compliance matters. She is committed to helping companies responsibly develop and market products, drawing on her years of experience advising the nation’s leading dietary supplement and food companies on complex ingredient and labeling issues.
Rend’s practice focuses on reviewing product labeling, ingredients, and advertising to determine compliance with federal and state regulations, and assisting companies in matters before the Food and Drug Administration (FDA), Federal Trade Commission (FTC), and National Adverting Division (NAD). She also advises clients on compliance with California’s Proposition 65, U.S. Customs issues, class action defense strategies, and FDA matters including Warning Letters, recalls, detentions, seizures, and import alerts.
Noah Voreadas
Nalin Siriwardhana
Mike Rogers
Michael Bush
Mike has more than 25 years of experience leading venture-backed businesses in the natural products, healthcare and bioinformatics industries. As president and CEO of probiotic innovator Ganeden, Michael grew the market of the company’s patented ingredient to over 65 countries and more than 1,000 SKUS, culminating with the 2017 merger with Kerry, Inc. Additionally, he founded a national business growth consultancy firm, co-founded a national biomedical services firm and led acquisitions and merger activities for a global medical services company.
Len Monheit
A recognized industry analyst and thought leader, Len Monheit has over 20 years experience in the natural products and dietary supplement industry, with over 15 years background in digital media. Monheit has participated in dozens of speaking engagements across four continents, talking about best business practices, industry trends across the health and wellness industries, and success factors for international business development.
With a background in Biopharma and biotechnology, and as General Manager of a contract research and analytical lab, Monheit, in 1999, co-founded NPIcenter, which grew over the subsequent 8 years, to be the largest online media enterprise in the North American Natural Products industry. Selling that to Penton Media’s New Hope Natural Media in 2006, Monheit joined Penton/New Hope as digital media director, ingredient portfolio manager, market leader and ultimately Executive Director of Strategic Business Development.
Taking on the role of General Manager, US, with UK-based William Reed Business Media, Monheit, over three years, introduced two new annual conferences to the US (Food Vision and Probiota) and was responsible for a tradeshow launch (The Healthy & Natural Show) in Chicago in May of 2016. Monheit had responsibility for all of William Reed’s activities in the Americas, including FoodNavigator-USA, NutraIngredients-USA, as well as Pharma and Cosmetics publications, in addition to international partnerships and growth projects.
Kevin Honaker
Kevin Honaker is co-founder and CEO of BiomeSense, an early stage life sciences startup developing a novel biosensor that enables continuous gut microbiome tracking in the home. Kevin has worked in health care for the past 7 years and is passionate about identifying, developing and commercializing new technologies that can improve health. Prior to joining BiomeSense, he led operations for PrescriptIQ, a pharmacogenomics startup, primarily responsible for strategic planning, finance, and product development. Kevin earned an MBA with honors from the University of Chicago Booth School of Business.
Kate Brunson
Justin Sonnenburg
Dr. Sonnenburg's lab is interested in the basic principles that govern interactions within the intestinal microbiota and between the microbiota and the host. To pursue these aims, they colonize germ-free (gnotobiotic) mice with simplified, model microbial communities, apply systems approaches (e.g. functional genomics), and use genetic tools for the host and microbes to gain mechanistic insight into emergent properties of the host-microbial super-organism.
